Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Bone Marrow Neoplasms × SCIO-469 × Myeloid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Myelodysplastic Syndromes 1 Hematologic Diseases 1 Bone Marrow Neoplasms 1 Bone Marrow Diseases 1

Interventions

ruxolitinib 1 Stem Cell Transplantation 1 SCIO-469 1 Hydroxyurea 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00113893 2013-11-07

SCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes.

Scios, Inc.

Phase 2 Completed

Bone Marrow Diseases, Hematologic Diseases, Myelodysplastic Syndromes, Bone Marrow Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡